Back to Search Start Over

Activation of Factor XII and Kallikrein-Kinin System Combined with Neutrophil Extracellular Trap Formation in Diabetic Retinopathy.

Authors :
Song, Da Young
Gu, Ja-Yoon
Yoo, Hyun Ju
Kim, Young Il
Nam-Goong, Il Sung
Kim, Eun Sook
Kim, Hyun Kyung
Source :
Experimental & Clinical Endocrinology & Diabetes. 2021, Vol. 129 Issue 8, p560-565. 6p.
Publication Year :
2021

Abstract

Background In diabetic retinopathy (DR), neutrophil extracellular traps (NET) and kallikrein-kinin system are considered as contributing factors. However, the detail activation mechanisms has not been fully understood. Since the NET could provide negative-charged surface for factor XII activation and the activated factor XII (XIIa) can initiate kallikrein-kinin system, this study investigated whether patients with DR show activation of NET, factor XII and kallikrein-kinin system. Methods The markers related to NET (DNA-histone complex) and kallikrein-kinin system (high-molecular-weight kininogen, prekallikrein, bradykinin) and factor XIIa were measured in 253 patients with diabetes. To access ex vivo effect of glucose, DNA-histone complex and factor XIIa were measured in whole blood stimulated by glucose. Results The circulating level of DNA-histone complex and factor XIIa were significantly higher in patients with DR than those without DR. In logistic regression analysis, DNA-histone complex, factor XIIa, and high-molecular-weight kininogen were the risk factors of DR. In recursive partitioning analysis, among patients with diabetes duration less than 10 years, patients with high level of DNA-histone complex (>426 AU) showed high risk of DR. In ex vivo experiment, glucose significantly elevated both DNA-histone complex and factor XIIa. Conclusion Our findings suggest that activation of factor XII and kallikrein-kinin system combined with NET formation actively occur in patients with DR and circulating levels of DNA-histone complex, factor XIIa and HMWK can be potential biomarkers to estimate the risk of DR. Strategies against factor XII activation may be beneficial to inhibit DR. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09477349
Volume :
129
Issue :
8
Database :
Academic Search Index
Journal :
Experimental & Clinical Endocrinology & Diabetes
Publication Type :
Academic Journal
Accession number :
151814394
Full Text :
https://doi.org/10.1055/a-0981-6023